advertisement
He Y 47
Showing records 1 to 25 | Display all abstracts from He Y125005 Glaucomatous retinal ganglion cells: death and protection
Cui N
International Journal of Ophthalmology 2025; 18: 160-167
125049 Comprehensive Proteomic Profiling of Exfoliation Glaucoma Via Mass Spectrometry Reveals SVEP1 as a Potential Biomarker
Li J
Investigative Ophthalmology and Visual Science 2025; 66: 19
127062 Efficacy of ultrasound cyclo-plasty in treatment of glaucoma in Asian population
Ge P
International Journal of Ophthalmology 2025; 18: 549-556
125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
He CZ
Frontiers in pharmacology 2025; 16: 1521358
126058 Genetic diversity and dietary adaptations of the Central Plains Han Chinese population in East Asia
Qiao X
Communications biology 2025; 8: 291
125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
Qiu Q
Frontiers in pharmacology 2025; 16: 1521358
126058 Genetic diversity and dietary adaptations of the Central Plains Han Chinese population in East Asia
Shi J
Communications biology 2025; 8: 291
125005 Glaucomatous retinal ganglion cells: death and protection
Jia J
International Journal of Ophthalmology 2025; 18: 160-167
125049 Comprehensive Proteomic Profiling of Exfoliation Glaucoma Via Mass Spectrometry Reveals SVEP1 as a Potential Biomarker
Ma Y
Investigative Ophthalmology and Visual Science 2025; 66: 19
127062 Efficacy of ultrasound cyclo-plasty in treatment of glaucoma in Asian population
Yang J
International Journal of Ophthalmology 2025; 18: 549-556
126058 Genetic diversity and dietary adaptations of the Central Plains Han Chinese population in East Asia
Xu H
Communications biology 2025; 8: 291
125005 Glaucomatous retinal ganglion cells: death and protection
He Y
International Journal of Ophthalmology 2025; 18: 160-167
125049 Comprehensive Proteomic Profiling of Exfoliation Glaucoma Via Mass Spectrometry Reveals SVEP1 as a Potential Biomarker
Xie L
Investigative Ophthalmology and Visual Science 2025; 66: 19
127062 Efficacy of ultrasound cyclo-plasty in treatment of glaucoma in Asian population
Xi JW
International Journal of Ophthalmology 2025; 18: 549-556
125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
Lu SJ
Frontiers in pharmacology 2025; 16: 1521358
125049 Comprehensive Proteomic Profiling of Exfoliation Glaucoma Via Mass Spectrometry Reveals SVEP1 as a Potential Biomarker
Zhuo K
Investigative Ophthalmology and Visual Science 2025; 66: 19
127062 Efficacy of ultrasound cyclo-plasty in treatment of glaucoma in Asian population
Sang W
International Journal of Ophthalmology 2025; 18: 549-556
125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
Xue FL
Frontiers in pharmacology 2025; 16: 1521358
126058 Genetic diversity and dietary adaptations of the Central Plains Han Chinese population in East Asia
Liu K
Communications biology 2025; 8: 291
125860 Adverse event reporting of faricimab: a disproportionality analysis of FDA adverse event reporting system (FAERS) database
Liu JQ
Frontiers in pharmacology 2025; 16: 1521358
126058 Genetic diversity and dietary adaptations of the Central Plains Han Chinese population in East Asia
Pu Y
Communications biology 2025; 8: 291
125049 Comprehensive Proteomic Profiling of Exfoliation Glaucoma Via Mass Spectrometry Reveals SVEP1 as a Potential Biomarker
He Y
Investigative Ophthalmology and Visual Science 2025; 66: 19
127062 Efficacy of ultrasound cyclo-plasty in treatment of glaucoma in Asian population
Yang XX
International Journal of Ophthalmology 2025; 18: 549-556
126058 Genetic diversity and dietary adaptations of the Central Plains Han Chinese population in East Asia
Xue X
Communications biology 2025; 8: 291
125049 Comprehensive Proteomic Profiling of Exfoliation Glaucoma Via Mass Spectrometry Reveals SVEP1 as a Potential Biomarker
Ma X
Investigative Ophthalmology and Visual Science 2025; 66: 19
